一种新的选择性化酶9抑制剂,irsenontrine (E2027),增强神经元中的GluA1酸化,并通过循环GMP升高改善学习和记忆
Yasuharu Ishihara1, Mai Ando2, Yasuaki Goto2
1Deep Human Biology Learning, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, 300-2635, Japan; Laboratory of Genomics-based Drug Discovery, Doctoral Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, Degree Program in Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8577, Japan.
伊尔森氨酸是一种新型的固酶9抑制剂,通过增加循环GMP (cGMP) 水平来增强学习和记忆. 这表明它作为治疗阿尔茨海默氏症等疾病的认知功能障碍的潜在疗法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 固酶9 (PDE9) 抑制可以改善认知功能和突触可塑性.
- NO/cGMP/PKG通路在阿尔茨海默氏症 (AD) 和患有莱维体痴呆症 (DLB) 中受到下调.
- PDE9抑制剂代表了与痴呆症相关的认知功能障碍的潜在治疗策略.
研究的目的:
- 评估一种新型PDE9抑制剂 - - 爱尔森氨酸在改善认知功能的有效性.
- 调查伊尔森诺林在调节循环GMP (cGMP) 水平和突触可塑性的作用机制.
主要方法:
- 评估了爱尔森氨酸对PDE9的选择性,而不是其他固酶.
- 在大鼠皮层神经元和大脑组织中测量了细胞内cGMP水平.
- 使用新型物体识别测试对原始和l-NAME治疗的老鼠进行学习和记忆的评估.
主要成果:
- 伊尔森氨酸对PDE9.9具有很高的选择性 (>1800倍).
- 艾尔森氨酸增加了细胞内cGMP水平,导致GluA1酸化.
- 口服伊尔森林改善了老鼠的学习和记忆,包括那些认知功能受损的老鼠.
结论:
- 伊尔森诺丁氨酸有效地增加了cGMP水平,并增强了认知功能.
- 伊尔森丁的机制涉及cGMP的升高,这表明它在认知障碍中的治疗作用.
- 伊尔森诺丁林显示出作为一种与痴呆症,AD和DLB相关的认知功能障碍的新治疗方法的承诺.
相关概念视频
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...


